Routine antenatal anti-D prophylaxis in pregnant women who are Rhesus D-negative during week 28 to 30 of pregnancy could help prevent hemolytic disease in their babies, according to a study published in Acta Obstetricia et Gynecologica Scandinavica. The retrospective review involved a cohort of all RhD-immunized pregnant women in Stockholm between 1990 and 2008. Researchers also said that first-trimester fetal RHD gene screening allows for selective administration of RAADP to RhD-negative women with an RHD-positive fetus.

Related Summaries